ライフサイエンスコーパス: neuroectodermal tumor

1 al teratoid/rhabdoid tumor and CNS primitive neuroectodermal tumor).

2 of the chest wall, and peripheral primitive neuroectodermal tumor.

3 stoma, choroid plexus carcinoma, and primary neuroectodermal tumor.

4 the neuroblastic rosettes in human primitive neuroectodermal tumors.

5 neuroblastomas to Ewing's sarcoma/peripheral neuroectodermal tumors.

6 nificantly, CD155 is aberrantly expressed in neuroectodermal tumors.

7 g development and the expression of CD155 in neuroectodermal tumors.

8 nt of Ewing's sarcoma and related peripheral neuroectodermal tumors.

9 also thought to be etiological in primitive neuroectodermal tumors.

10 anslocation in Ewing's sarcoma and primitive neuroectodermal tumors.

11 creaticoblastomas and 1 of 10 with primitive neuroectodermal tumors.

12 eleted in neuroblastoma, melanoma, and other neuroectodermal tumors.

13 mmon mechanism in the causation of primitive neuroectodermal tumors.

14 Among sarcomas, 21 of 21 Ewing's/primitive neuroectodermal tumor, 28 of 29 rhabdomyosarcomas, 28 of

15 g of treatment: medulloblastoma or primitive neuroectodermal tumors, 57.8; germ cell tumors, 63.5; ep

16 Ganglioside GD2 is highly expressed on neuroectodermal tumors and an attractive therapeutic tar

17 as found to be overexpressed in a variety of neuroectodermal tumors and described as an essential ang

18 involved in Ewing sarcoma, related primitive neuroectodermal tumors and desmoplastic small round cell

19 se (PR) in two patients with Ewing/primitive neuroectodermal tumors and included one PR and one minor

20 eosarcomas, one Ewing sarcoma, one primitive neuroectodermal tumor, and one desmoplastic small round

21 of gliomas, central nervous system primitive neuroectodermal tumors, and atypical teratoid/rhabdoid-l

22 blastomas (MBs) and supratentorial primitive neuroectodermal tumors, and we report the outcome in the

23 ise Ewing's sarcoma and peripheral primitive neuroectodermal tumors, are highly aggressive and mostly

24 multilayered rosettes (ETMRs) are primitive neuroectodermal tumors arising in infants.

25 hed GEM models of medulloblastoma, primitive neuroectodermal tumor, astrocytoma, oligodendroglioma, m

26 rentiated sarcoma, and soft tissue primitive neuroectodermal tumor at all sites except paratesticular

27 y SCLC cultures as well as in some primitive neuroectodermal tumor biopsies.

28 as, and cell lines derived from a variety of neuroectodermal tumors by Northern analysis and in situ

29 Using a human peripheral primitive neuroectodermal tumor cell line, SK-N-MC, we demonstrate

30 Neuroectodermal tumor cell lines derived from other site

31 The GD2 ganglioside expressed on neuroectodermal tumor cells has been used as a target fo

32 TF4 mediates ER stress-induced cell death of neuroectodermal tumor cells in response to fenretinide o

33 strates, in contrast to cells from primitive neuroectodermal tumors cells (n=6), which only migrated

34 lastoma and central nervous system primitive neuroectodermal tumors (CNS-PNET) are aggressive, poorly

35 eipt of AC, or if pure teratoma or primitive neuroectodermal tumor elements were found in the retrope

36 ade glioma, 32 had medulloblastoma/primitive neuroectodermal tumor/embryonal tumor, 17 had malignant

37 or medulloblastoma, supratentorial primitive neuroectodermal tumor, ependymoma, and rhabdoid tumors,

38 s of patients with Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) metastatic to bone/bone

39 Ewings sarcoma and primitive neuroectodermal tumors (ES/PNET) are characterized by th

40 Primary renal primitive neuroectodermal tumor/extraskeletal Ewing's sarcoma (PNE

41 allmark of the Ewing's sarcoma and primitive neuroectodermal tumor family, encodes a fusion protein w

42 ingle cell type (two patients with primitive neuroectodermal tumors, five with undifferentiated RMS,

43 with pathology consistent with grade III-IV neuroectodermal tumors in mice.

44 uld raise the suspicion of a renal primitive neuroectodermal tumor, in a young adult.

45 evidence for the development of inheritable neuroectodermal tumors induced by the human polyomavirus

46 One hallmark of Ewing's sarcoma/peripheral neuroectodermal tumors is the presence of the Ews/Fli-1

47 gene found in Ewing's sarcoma and primitive neuroectodermal tumor, is able to transform certain cell

48 ntaining tumors, brain lymphoma or primitive neuroectodermal tumor make use of systemic administratio

49 Since primitive neuroectodermal tumors/medulloblastomas (PNETs/medullobl

50 foci of yolk sac tumor (n = 21) or primitive neuroectodermal tumor (n = 2), whereas 50 had pure immat

51 pendymoma (n = 8), medulloblastoma/primitive neuroectodermal tumor (n = 4), glioblastoma multiforme (

52 m glioma (n = 7), medulloblastoma/peripheral neuroectodermal tumor (n = 6), ependymoma (n = 3), and p

53 The neuroectodermal tumors neuroblastoma and melanoma repres

54 ithout a bone sarcoma (ie, neither primitive neuroectodermal tumor nor osteosarcoma) (HR for PFS, 0.3

55 Ewing's sarcoma and primitive neuroectodermal tumor of bone are closely related, highl

56 n patients with Ewing's sarcoma or primitive neuroectodermal tumor of bone who had a relapse after st

57 ith nonmetastatic Ewing's sarcoma, primitive neuroectodermal tumor of bone, or primitive sarcoma of b

58 d or younger with Ewing's sarcoma, primitive neuroectodermal tumor of bone, or primitive sarcoma of b

59 Primitive neuroectodermal tumors of the central nervous system (CN

60 or = 30 years with Ewing sarcoma, primitive neuroectodermal tumor or primitive sarcoma of bone were

61 ren treated for medulloblastoma or primitive neuroectodermal tumor (PNET) and document the associated

62 of Ewing's Sarcoma and peripheral Primitive Neuroectodermal Tumor (PNET) are associated with aberran

63 Medulloblastoma (MB) and primitive neuroectodermal tumor (PNET) are histologically similar

64 imaging of brain involvement with primitive neuroectodermal tumor (PNET) demonstrated mild hypometab

65 the Ewing sarcoma (ES)/peripheral primitive neuroectodermal tumor (PNET) family are pediatric cancer

66 with metastatic Ewing's sarcoma or primitive neuroectodermal tumor (PNET) of bone were entered onto a

67 loblastoma, central nervous system primitive neuroectodermal tumor (PNET), and astrocytoma before 6 y

68 medulloblastoma or supratentorial primitive neuroectodermal tumor (PNET).

69 c patients with medulloblastoma or primitive neuroectodermal tumor (PNET).

70 Ten of 20 (50%) patients (primitive neuroectodermal tumor (PNET)/medulloblastoma, three pati

71 genic (OS) and Ewing's (ES) and/or primitive neuroectodermal tumor (PNET)] sarcoma, treated with chem

72 ma and 158 children diagnosed with primitive neuroectodermal tumors (PNET) in the United States and C

73 loped bilateral retinoblastoma and primitive neuroectodermal tumors (PNET) of the midbrain.

74 such as Ewing's sarcoma (EWS) and primitive neuroectodermal tumors (PNET), are highly aggressive mal

75 mice to the human medulloblastoma/primitive neuroectodermal tumor (PNETs) in location, histologic ap

76 Primitive neuroectodermal tumors (PNETs) are a family of primary m

77 Primitive neuroectodermal tumors (PNETs) of the central nervous sy

78 Primitive neuroectodermal tumors (PNETs) of the central nervous sy

79 ions in medulloblastomas and other primitive neuroectodermal tumors (PNETs) of the childhood CNS we p

80 (HASH1) in cerebellar and cerebral primitive neuroectodermal tumors (PNETs), gliomas, and cell lines

81 s to the development of cerebellar primitive neuroectodermal tumors (PNETs).

82 neuroblastoma, pineoblastoma, and primitive neuroectodermal tumors (PNETs).

83 rade glioma and in two of six with primitive neuroectodermal tumors (PNETs)/ medulloblastoma.

84 PR) in one patient with peripheral primitive neuroectodermal tumor (PPNET), and a minimal response (M

85 onal renal cell carcinoma, 100% of primitive neuroectodermal tumors, renal malignant masenchymomas an

86 We have analyzed a primitive neuroectodermal tumor sample exhibiting loss of heterozy

87 lly Ewing's sarcoma and peripheral primitive neuroectodermal tumor, share a common class of tumor-spe

88 hereas experimental supratentorial primitive neuroectodermal tumors (sPNET) correspond to atypical te

89 of a panel of human supratentorial primitive neuroectodermal tumors (sPNET) showed low activity of th

90 and Type II) are differentially expressed in neuroectodermal tumor tissue relative to differentiated

91 a new approach to the treatment of primitive neuroectodermal tumors we evaluated the effect of the HM

92 tem NSCs generated medulloblastoma/primitive neuroectodermal tumors, whereas forebrain NSCs developed

93 ic animals that develop cerebellar primitive neuroectodermal tumors which model human medulloblastoma

94 ansformed with N-Myc, we generated primitive neuroectodermal tumors with divergent differentiation in